Loading insider details...
Latest Form 4 (Nov 12, 2026): Purchase of 1,200 AQST shares, $4.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Aquestive Therapeutics, Inc. (AQST) | Purchase | 1,200 | $4.2K |
| Nov 10, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 57,000 | n/a |
| Jul 17, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to Issuer | 271,266 | $8.54M |
| Jan 6, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 42,105 | n/a |
| Dec 30, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,334 | n/a |
| Nov 25, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 20,006 | n/a |
| Aug 28, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 50,000 | $112.0K |
| Jun 3, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Sale | 70,000 | $1.74M |
| Feb 19, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 4,000 | n/a |
| Jan 3, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 42,105 | n/a |